In adults with CF, Olveira et al. [11] showed that low-dose supplements of omega-3 and gamma-linolenic fatty acids administered for 1 year was associated with a significant reduction of serum TNF-α and its soluble receptors. Here, TNF is linked to cystic fibrosis.